2024. Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s453. DOI:https://doi.org/10.25251/skin.8.supp.453.